The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...
5d
Zacks Investment Research on MSNPositive Trial Data on Evolut TAVR Likely to Support MDT StockMedtronic plc MDT recently unveiled two-year Small Annuli Randomized to Evolut or SAPIEN (“SMART”) Trial results at the Cardiovascular Research Technologies (“CRT”) 2025 conference in Washington, D.C.
Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Medtronic : Data Confirms Superior Valve Performance Of Evolut TAVR System In Small Annulus Patients
(RTTNews) - Medtronic plc (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, international head-to-head comparative trial of transfemoral ...
Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...
Hosted on MSN11mon
Medtronic’s TAVR system proves superior in womenBoth TAVR and surgical aortic valve replacement (SAVR) are options for women to treat aortic stenosis, but due to their smaller aortic annuli, women can often receive a valve replacement that does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results